Right treatment, right person: Precision Medicine in action right now

Te Aka Symposium speaker Josh McMillan in the news supporting Canteen

Revolutionary cancer drug developed in Auckland set to begin clinical trials

Professor Andrew Shelling’s recent trip to Spain for the EACR congress

Flagship research centres to tackle urgent societal challenges

All the cancer you cannot see